Neurologic evaluation of workers previously diagnosed with solvent- induced toxic encephalopathy

Journal of Occupational and Environmental Medicine

Volumn 42, Issue 4, 2000, Pages 410-423

  Albers, James W ^a,b,c,d,f   Wald, John J ^a   Garabrant, David H ^c   Trask, Christine L ^d,e   Berent, Stanley ^a,b,c,d,e  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^c UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

^d NeuroBehavioral Resources Inc   (United States)

^e UNIVERSITY OF MICHIGAN   (United States)

^f UNIVERSITY OF MICHIGAN HOSPITALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SOLVENT;

ADULT; BRAIN INJURY; CLINICAL ARTICLE; DRUG INDUCED DISEASE; EYELID REFLEX; FEMALE; HUMAN; INTOXICATION; MALE; NERVE CONDUCTION; NEUROLOGIC DISEASE; NEUROTOXICITY; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCUPATIONAL EXPOSURE; PERIPHERAL VASCULAR DISEASE; REVIEW; WORK ENVIRONMENT;

EID: 0033993791     PISSN: 10762752     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043764-200004000-00017     Document Type: Review

References (66)

1. Chang CM, Yu CW, Fong KY, et al. n-Hexane neuropathy in offset printers. J Neurol Neurosurg Psychiatry. 1993;56: 538-542.
2. Scelsi R, Poggi P, Fera L, Gonella G. Industrial neuropathy due to n-hexane: clinical and morphological findings in three cases. Clin Toxicol. 1981;18:1387-1393.
3. Herskowitz A, Ishii N, Schaumburg HH. n-Hexane neuropathy. A syndrome occurring as a result of industrial exposure. N Engl J Med. 1971;285:82-85.
4. Paulson GW, Waylonis GW. Polyneuropathy due to n-hexane. Arch Intern Med. 1976;136:880-882.
5. Iida M. Neurophysiological studies in n-hexane polyneuropathy in the sandal factory. Electroencephalogr Clin Neurophysiol. 1982;36(suppl):671-681.
6. Spencer PS, Schaumburg HH, Raleigh RL, Terhaar CJ. Nervous system degeneration produced by the industrial solvent methyl n-butyl ketone. Arch Neurol. 1975;32:219-222.
7. Spencer PS, Schaumburg HH. Organic solvent neurotoxicity: facts and research needs. Scand J Work Environ Health. 1985:11(suppl 1):53-60.
8. Baker EL, Fine LJ. Solvent neurotoxicity: the current evidence. J Occup Med. 1986;28:126-129.
9. Maizlish NA, Fine LJ, Albers JW, Whitehead L, Langolf GD. A neurological evaluation of workers exposed to mixtures of organic solvents. Br J Ind Med. 1987;44:14-25.
10. Bleecker ML, Bolla KI, Agnew J, Schwartz BS. Dose-related subclinical neurobehavioral effects of chronic exposure to low levels of organic solvents. Am J Ind Med. 1991;19:715-728.
11. Waters EM, Gerstner HB, Huff JE. Trichloroethylene. I. An overview. J Toxicol Environ Health. 1977;2:671-701.
12. Leech PN. The use of trichloroethylene for general anesthesia. JAMA. 1936;13C-130.
13. Rosenberg NL. Neurotoxicity of organic solvents. In: Rosenberg NL, ed. Occupational and Environmental Neurology. Boston: Butterworth-Heinemann; 1995: 71-113.
14. Buxton PH, Hayward M. Polyneuritis cranialis associated with industrial trichloroethylene poisoning. J Neurol Neurosurg Psychiatry. 1967;30:511-518.
15. Humphrey JH, McClelland M. Cranialnerve palsies with herpes following general anaesthesia. Br Med J. 1944;4:315-318.
16. Feldman RG, Mayer RM, Taub A. Evidence for peripheral neurotoxic effect of trichloroethylene. Neurology. 1970;20: 599-606.
17. Arlien-Soborg P, Henriksen L, Gade A, Gyldensted C, Paulson OB. Cerebral blood flow in chronic toxic encephalopathy in house painters exposed to organic solvents. Acta Neurol Scand. 1982;66: 34-41.
18. Arlien-Soborg P, Bruhn P, Gyldensted C, Melgaard B. Chronic painters' syndrome. Chronic toxic encephalopathy in house painters. Acta Neurol Scand. 1979;60: 149-156.
19. Gade A, Mortensen L, Bruhn P. "Chronic painter's syndrome." A reanalysis of psychological test data in a group of diagnosed cases, based on comparisons with matched controls. Acta Neurol Scand. 1988;77:293-306.
20. Maizlish NA, Langolf GD, Whitehead LW, et al. Behavioural evaluation of workers exposed to mixtures of organic solvents. Br J Ind Med. 1985;42:579-590.
21. Baker EL, Jr, Smith TJ, Landrigan PJ. The neurotoxicity of industrial solvents: a review of the literature. Am J Ind Med. 1985;8:207-217.
22. Linz DH, Morton WE, Wiens AN, Coull BM, Maricle RA. Organic solvent-induced encephalopathy in industrial painters. J Occup Med. 1986;28:119-125.
23. Taubes G. Epidemiology faces its limits. Science. 1995;269:164-169.
24. Workshop on solvent exposure among railroad workers. Organized by the Association of Occupational Environmental Clinics; Sponsored by NIOSH; November 6-7, 1996; Washington, D.C.
25. Frumkin H, Ducatman A, Kirkland K. Solvent exposure in the railroad industry (letter). J Occup Environ Med. 1997;39: 926-930.
26. World Health Organization. Chronic Effects of Organic Solvents on the Central Nervous System and Diagnostic Criteria. Copenhagen: WHO and Nordic Council of Ministers; 1985.
27. Edling C, Ekberg K, Ahlborg G Jr, Alexandersson R. Long term follow up of workers exposed to solvent. Br J Ind Med. 1990;47:75-82.
28. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state." A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975; 12:189-198.
29. Albers JW, Wald JJ, Werner RA, Franz-blau A, Berent S. Absence of poly neuropathy among workers previously diagnosed with solvent-induced toxic encephalopathy. J Occup Environ Med. 1999;41:500-509.
30. Dyck PJ. Detection, characterization, and staging of polyneuropathy: assessed in diabetes. Muscle Nerve. 1988;11:21-32.
31. Dyck PJ, Litchy WJ, Lehman KA, Hokanson JL, Low PA, O'Brien PC. Variables influencing neuropathic endpoints: the Rochester Diabetic Neuropathy Study of Healthy Subjects. Neurology. 1995;45: 1115-1121.
32. Schoenberg VS. Descriptive neuroepidemiology: applications to occupational neurology. Acta Neurol Scand. 1982; 66(suppl 92):1-9.
33. Guberan E, Usel M, Raymond L, Tissot R, Sweetnam PM. Disability, mortality, and incidence of cancer among Geneva painters and electricians: a historical prospective study. Br J Ind Med. 1989;46: 16-23.
34. Riise T, Kyvik KR, Moen B. A cohort study of disability pensioning among Norwegian painters, construction workers, and workers in food processing. Epidemiology. 1995;6:132-136.
35. van Vliet C, Swaen GMH, Slangen JJM, de Boorder T. The organic solvent syndrome. A comparison of cases with neuropsychiatric disorders among painters and construction workers. Int Arch Occup Environ Health. 1987;59:493-501.
36. Williamson AM, Winder C. A prospective cohort study of the chronic effects of solvent exposure. Environ Res. 1993;62: 256-271.
37. Lundberg I, Gustavsson A, Hogberg M, Nise G. Diagnoses of alcohol abuse and other neuropsychiatric disorders among house painters compared with house carpenters. Br J Ind Med. 1992;49:409-415.
38. Mikkelsen S. A cohort study of disability pension and death among painters with special regard to disabling presenile dementia as an occupational disease. Scand J Soc Med Suppl. 1980;16:34-43.
39. Cherry NM, Labreche FP, McDonald JC. Organic brain damage and occupational solvent exposure. Br J Ind Med. 1992;49: 776-781.
40. Riise T, Moen BE. A nested case-control study of disability pension among seamen, with special reference to neuropsychiatric disorders and exposure to solvents. Neuroepidemiology. 1990;9:88-94.
41. van Vliet C, Swaen GM, Volovics A, et al. Exposure-outcome relationships between organic solvent exposure and neuropsychiatric disorders: results from a Dutch case-control study. Am J Ind Med. 1989;16:707-718.
42. Olsen J, Sabroe S. A case-reference study of neuropsychiatric disorders among workers exposed to solvents in the Danish wood and furniture industry. Scand J Soc Med. 1998;16:44-49.
43. Brackbill RM, Maizlish N, Fischbach T. Risk of neuropsychiatric disability among painters in the United States. Scand J Work Environ Health. 1990;16: 182-188.
44. van Vliet C, Swaen GM, Volovics A, et al. Neuropsychiatric disorders among solvent-exposed workers. First results from a Dutch case-control study. Int Arch Occup Environ Health. 1990;62:127-132.
45. Axelson O, Hane M, Hogstedt C. A case-referent study on neuropsychiatric disorders among workers exposed to solvents. Scand J Work Environ Health. 1976;2:14-20.
46. Labreche FP, Cherry NM, McDonald JC. Psychiatric disorders and occupational exposure to solvents. Br J Ind Med. 1992;49:820-825.
47. Nelson NA, Robins TG, White RF, Garrison RP. A case-control study of chronic neuropsychiatric disease and organic solvent exposure in automobile assembly plant workers. Occup Environ Med. 1994;51:302-307.
48. Lindstrom K, Riihimaki H, Hanninen K. Occupational solvent exposure and neuropsychiatric disorders. Scand J Work Environ Health. 1984;10:321-323.
49. O'Flynn RR, Monkman SM, Waldron HA. Organic solvents and presenile dementia: a case referent study using death certificates. Br J Ind Med. 1987;44:259-262.
50. Palmer K, Inskip H, Martyn C, Coggon D. Dementia and occupational exposure to organic solvents. Occup Environ Med. 1998;55:712-715.
51. Shalat SL, Seltzer B, Baker EL Jr. Occupational risk factors and Alzheimer's disease: a case-control study. J Occup Med. 1988;30:934-936.
52. Graves AB, Rosner D, Echeverria D, Mortimer JA, Larson EB. Occupational exposures to solvents and aluminum and estimated risk of Alzheimer's disease. Occup Environ Med. 1998;55:627-633.
53. Juntunen J, Kinnunen E, Antti-Poika M, Koskenvuo M. Multiple sclerosis and occupational exposure to chemicals: a co-twin control study of a nationwide series of twins. Br J Ind Med. 1989;46: 417-419.
54. Brown DL, Smith TL, Knepper LE. Evaluation of five primitive reflexes in 240 young adults. Neurology. 1998;51:322.
55. Jacobs L, Gossman D. Three primitive reflexes in normal adults. Neurology. 1980;30:184-188.
56. Rothstein JD, Herlong HF. Neurologic manifestations of hepatic disease. In: Riggs JE, ed. Neurologic Manifestations of Systemic Disease. Philadelphia: Saunders; 1989:563-579.
57. Riordan SM, Williams R. Treatment of hepatic encephalopathy. N Engl J Med. 1997;337:473-479.
58. Levy DE, Caronna JJ, Singer BH, et al. Predicting outcome from hypoxicischemic coma. JAMA. 1985;253:1420-1426.
59. Markand ON. Electroencephalography in diffuse encephalopathies. J Clin Neurophysiol. 1984;1:357-407.
60. Richardson WS, Wilson MC, Guyatt GH. Cook DJ, Nishikawa J. Users' guides to the medical literature: XV. How to use an article about disease probability for differential diagnosis. Evidence-Based Medicine Working Group. JAMA. 1999; 281:1214-1219.
61. Sox HC, Blatt MA, Higgins MC, Marton KI. Medical Decision Making. Boston: Butterworth; 1988.
62. Differential Diagnosis. Philadelphia: Lea & Febiger; 1994.
63. Newman S, Klinger L, Venn G, Smith P, Harrison M, Treasure T. Subjective reports of cognition in relation to assessed cognitive performance following coronary artery bypass surgery. J Psychosom Res. 1989;33:227-233.
64. Strub RL, Black FW. Neurobehavioral Disorders: A Clinical Approach. Philadelphia: F.A. Davis; 1992:169-172.
65. Sahakian BJ. Depressive pseudodementia in the elderly. Int J Geriatric Psychiatry. 1991;6:453-458.
66. Albers JW. Evaluation of the patient with suspected peripheral neuropathy. In: Johnson EW, Pease WS, eds. Practical Electromyography. Baltimore: Williams & Wilkins; 1997:311-337.